Invesco
ELVN icon

Invesco’s Enliven Therapeutics ELVN Stock Holding History

Invesco’s Portfolio ELVN Stock Details ELVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.42M Buy
61,752
+37,032
+150% +$1.03M ﹤0.01% 2458
2025
Q4 		$381K Buy
24,720
+1,624
+7% +$32.4K ﹤0.01% 3299
2025
Q3 		$473K Buy
23,096
+1,139
+5% +$23K ﹤0.01% 3241
2025
Q2 		$440K Buy
21,957
+913
+4% +$17.3K ﹤0.01% 3211
2025
Q1 		$414K Buy
21,044
+5,972
+40% +$129K ﹤0.01% 3227
2024
Q4 		$339K Buy
15,072
+508
+3% +$13.2K ﹤0.01% 3380
2024
Q3 		$372K Buy
14,564
+264
+2% +$6.11K ﹤0.01% 3345
2024
Q2 		$334K Buy
14,300
+1,811
+15% +$38.1K ﹤0.01% 3453
2024
Q1 		$220K Buy
12,489
+1
+0% +$15 ﹤0.01% 3612
2023
Q4 		$173K Sell
12,488
-6,278
-33% -$76.8K ﹤0.01% 3591
2023
Q3 		$256K Buy
+18,766
New +$316K ﹤0.01% 3511

Other funds holding ELVN

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return